Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
absence, add, approach, Ash, broader, buy, caution, Certificate, clarified, core, decline, detrimental, discourage, economic, enjoy, faith, FINRA, fragmented, France, hereto, herewith, IASB, importantly, indemnification, indemnifying, index, intense, intensely, investor, Italy, jointly, KDMP, Kedem, Korea, Lab, managerial, medium, mika, Mike, MK, NASD, needle, omitted, portion, Prima, prolonged, prominence, proportionate, rapidly, reader, reallocate, recommend, recommending, reduction, retrospectively, scale, short, shown, size, strain, strained, suggested, tangible, thereunto, top, undersigned, uniform, vary, Veda, viable, withstand, XBRL
Removed:
acting, agreed, February, foregoing, governance, hierarchy, paragraph, recurring, regulated, removed
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 Marketing and Distribution Agreement Date May 3, 2012 Between Our Company, Healthy Europe and Veda Lab.
- 10.3 Revised Distribution Agreement Dated June 25, 2012 Between Our Company, Our Subsidiary, MK Global Co. and Mika Medical Co.
- 14.1 Code of Business Conduct and Ethics
- 31.1 Section 302 Certifications Under Sarbanes-oxley Act of 2002
- 32.1 Section 906 Certifications Under Sarbanes-oxley Act of 2002
ETAH similar filings
Filing view
External links